Marc Edwards Acquires 2,000,000 Shares of Kane Biotech Inc. (CVE:KNE) Stock

Kane Biotech Inc. (CVE:KNE) Director Marc Edwards bought 2,000,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of C$0.10 per share, with a total value of C$200,000.00.

Kane Biotech Stock Down 4.5 %

Shares of KNE opened at C$0.11 on Friday. Kane Biotech Inc. has a fifty-two week low of C$0.08 and a fifty-two week high of C$0.17. The company’s fifty day moving average is C$0.11 and its two-hundred day moving average is C$0.13. The firm has a market cap of C$13.91 million, a PE ratio of -3.50 and a beta of 0.52. The company has a quick ratio of 0.39, a current ratio of 0.82 and a debt-to-equity ratio of 1,164.24.

Kane Biotech Company Profile

Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.